SERA PROGNOSTICS, INC. Professional Fees
SERA PROGNOSTICS, INC. (SERA) reported Professional Fees of $1.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2026-08-12
- SERA PROGNOSTICS, INC. professional fees for the quarter ending 2026-06-30 was $1.64M, a 19.64% decline year-over-year.
- SERA PROGNOSTICS, INC. professional fees for the quarter ending 2026-03-31 was $1.92M, a 4.91% increase year-over-year.
- SERA PROGNOSTICS, INC. professional fees for the quarter ending 2025-12-31 was $1.55M, a 37.42% decline year-over-year.
- SERA PROGNOSTICS, INC. professional fees for the quarter ending 2025-09-30 was $1.51M, a 14.17% decline year-over-year.
- SERA PROGNOSTICS, INC. professional fees for fiscal 2025 was $6.94M, a 8.40% decline from fiscal 2024.
- SERA PROGNOSTICS, INC. professional fees for fiscal 2024 was $7.58M, a 51.26% increase from fiscal 2023.
- SERA PROGNOSTICS, INC. professional fees for fiscal 2023 was $5.01M.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month | Professional Fees 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.64M 10-Q · filed 2026-08-12 | $3.56M 10-Q · filed 2026-08-12 | $5.12M derived: sum of 3 quarters · filed 2026-08-12 | $6.63M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $1.92M 10-Q · filed 2026-05-06 | $3.48M derived: sum of 2 quarters · filed 2026-05-06 | $4.99M derived: sum of 3 quarters · filed 2026-05-06 | $7.03M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $3.07M derived: sum of 2 quarters · filed 2026-03-18 | $5.11M derived: sum of 3 quarters · filed 2026-08-12 | $6.94M 10-K · filed 2026-03-18 |
| 2025-09-30 | $1.51M 10-Q · filed 2025-11-13 | $3.56M derived: sum of 2 quarters · filed 2026-08-12 | $5.39M 10-Q · filed 2025-11-13 | $7.87M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $2.04M 10-Q · filed 2026-08-12 | $3.88M 10-Q · filed 2026-08-12 | $6.36M derived: sum of 3 quarters · filed 2026-08-12 | $8.12M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $1.83M 10-Q · filed 2026-05-06 | $4.32M derived: sum of 2 quarters · filed 2026-05-06 | $6.08M derived: sum of 3 quarters · filed 2026-05-06 | $7.56M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $4.25M derived: sum of 2 quarters · filed 2026-03-18 | $5.73M derived: sum of 3 quarters · filed 2026-03-18 | $7.58M 10-K · filed 2026-03-18 |
| 2024-09-30 | $1.76M 10-Q · filed 2025-11-13 | $3.24M derived: sum of 2 quarters · filed 2025-11-13 | $5.10M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $1.48M 10-Q · filed 2025-08-06 | $3.33M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $1.85M 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $5.01M 10-K · filed 2025-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |